Homology Medicines Inc.

05/18/2022 | Press release | Distributed by Public on 05/18/2022 04:09

Homology Medicines Presents Details of Optimized HMI-103 Nuclease-Free Gene Editing Candidate Featuring Integrated Liver-Specific Promoter to Maximize Long-Term Expression